Table 2.
Comparisons of baseline characteristics between the sensitive and tolerance groups
| Baseline characteristics | Tolerance group (n=48) | Sensitive group (n=69) | P-value |
|---|---|---|---|
| Age (years) | 50.18±7.21 | 49.24±11.93 | 0.627 |
| Weight (kg) | 59.04±6.11 | 58.38±9.54 | 0.673 |
| Primary lesion | 0.826 | ||
| Laryngeal | 10 (20.83%) | 16 (23.19%) | |
| Partes oralis | 9 (18.75%) | 11 (14.94%) | |
| Hypopharynx | 22 (45.83%) | 28 (40.58%) | |
| Nasal cavity | 7 (14.58%) | 14 (20.29%) | |
| Maximum tumor diameter | 0.796 | ||
| <1 cm | 19 (39.58%) | 31 (44.93%) | |
| 1–2 cm | 14 (29.17%) | 20 (28.99%) | |
| >2 cm | 15 (31.25%) | 18 (26.09%) | |
| TNM staging | 0.567 | ||
| I | 6 (12.50%) | 14 (20.29%) | |
| II | 9 (18.75%) | 9 (13.04%) | |
| III | 17 (35.42%) | 27 (39.13%) | |
| IV | 16 (33.33%) | 19 (27.54%) | |
Abbreviation: TNM, tumor node metastasis.